Doseology Announces Extension to Closing of Private Placement

Executive Summary

• Doseology Sciences Inc. has received a 45-day extension from the Canadian Securities Exchange (CSE) to close its previously announced non-brokered private placement.
• The extension follows prior news releases dated March 30, 2026, and May 15, 2026.
• The private placement remains structured to raise up to $2,000,000 through the sale of units.

Key Details

• Extension Details: The Company received an additional 45-day extension from the CSE to close the Offering.
• Offering Structure: The Offering consists of up to 3,225,806 Units.
• Price: The price per Unit is $0.62.
• Gross Proceeds: The Offering aims to raise aggregate gross proceeds of up to $2,000,000.
• Transaction Type: Non-brokered private placement.
• Regulatory Context: The release notes that required regulatory approvals, including CSE approval, are still pending as part of the closing conditions.

Notable Quotes

• No direct quotes from management were included in the body of the release.